Another drug developer for the animal health field is going public. Parnell Pharmaceuticals outlined plans to raise $57.5 million in an IPO designed to fuel its work on new therapies for family pets as well as production animals.

…read more

Source: Another animal health biotech plots an IPO


0 No comments